Cargando…

Nanomodulation of Macrophages in Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic demyelinating autoimmune disease primarily affecting young adults. Despite an unclear causal factor, symptoms and pathology arise from the infiltration of peripheral immune cells across the blood brain barrier. Accounting for the largest fraction of this infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nally, Frances K., De Santi, Chiara, McCoy, Claire E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628349/ https://www.ncbi.nlm.nih.gov/pubmed/31195710 http://dx.doi.org/10.3390/cells8060543

Ejemplares similares

Polarization selective phase-change nanomodulator
por: Appavoo, Kannatassen, et al.
Publicado: (2014)

Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases
por: Shi, Yesi, et al.
Publicado: (2022)

Impact of Exercise on Immunometabolism in Multiple Sclerosis
por: Afzal, Remsha, et al.
Publicado: (2020)

The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
por: Duffy, Conor P., et al.
Publicado: (2020)

Synaptic nanomodules underlie the organization and plasticity of spine synapses
por: Hruska, Martin, et al.
Publicado: (2018)

Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy
por: Zheng, Pan, et al.
Publicado: (2022)

Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype
por: De Santi, Chiara, et al.
Publicado: (2022)

Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects
por: Farhana, Aisha
Publicado: (2023)

Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers
por: Fitzsimons, Stephen, et al.
Publicado: (2023)

Dynamic contrast-enhanced photoacoustic imaging using photothermal stimuli-responsive composite nanomodulators
por: Chen, Yun-Sheng, et al.
Publicado: (2017)

Molecular Mimicry in Multiple Sclerosis
por: Libbey, Jane E., et al.
Publicado: (2007)

In silico prioritisation of microRNA-associated common variants in multiple sclerosis
por: Fashina, Ifeolutembi A., et al.
Publicado: (2023)

Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy
por: Wang, Shuqi, et al.
Publicado: (2023)

Multifunctional Calcium–Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment
por: Luo, Guanghong, et al.
Publicado: (2023)

Biodegradable calcium sulfide-based nanomodulators for H(2)S-boosted Ca(2+)-involved synergistic cascade cancer therapy
por: Lin, Chuchu, et al.
Publicado: (2022)

Biomaterial and Therapeutic Approaches for the Manipulation of Macrophage Phenotype in Peripheral and Central Nerve Repair
por: Dervan, Adrian, et al.
Publicado: (2021)

The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis
por: Rawji, Khalil S., et al.
Publicado: (2013)

Manipulating Macrophage/Microglia Polarization to Treat Glioblastoma or Multiple Sclerosis
por: Kuntzel, Thomas, et al.
Publicado: (2022)

The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis
por: Monaghan, Kelly L., et al.
Publicado: (2020)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
por: Dowling, Jennifer K., et al.
Publicado: (2021)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2018)

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
por: Kamma, Emily, et al.
Publicado: (2022)

Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2023)

Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination
por: Prineas, John W, et al.
Publicado: (2021)

Pericytes as mediators of infiltration of macrophages in multiple sclerosis
por: Kaushik, Deepak Kumar, et al.
Publicado: (2021)

Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors
por: Leyva, Francisco J, et al.
Publicado: (2011)

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
por: Mancinelli, Chiara Rosa, et al.
Publicado: (2021)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

A cautionary note regarding detection of PD-L1 expression by tumour-associated macrophages
por: McCoy, Melanie J., et al.
Publicado: (2017)

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
por: McCoy, Melissa K, et al.
Publicado: (2008)

Standardised animal models of host microbial mutualism
por: Macpherson, A J, et al.
Publicado: (2015)

Tremor in multiple sclerosis
por: Koch, Marcus, et al.
Publicado: (2007)

Adaptive responses to salinity stress across multiple life stages in anuran amphibians
por: Albecker, Molly A., et al.
Publicado: (2017)

Cannabinoids in the management of spasticity associated with multiple sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2008)

Neutralizing antibodies to HIV-1 induced by immunization
por: McCoy, Laura E., et al.
Publicado: (2013)

Macrophages as determinants and regulators of fibrosis in systemic sclerosis
por: Al-Adwi, Yehya, et al.
Publicado: (2022)

Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
por: McCoy, Kathleen L.
Publicado: (2016)

Multiple Sclerosis
por: Gaby, Alan
Publicado: (2013)

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_63f2ojvc74nr7hugq9rn259sr0